U.S. Metals and Mining Stock News

NYSE:ENVA
NYSE:ENVAConsumer Finance

Enova International Expands Digital Lending Reach With Grasshopper Bancorp Acquisition

Enova International (NYSE:ENVA) announces an agreement to acquire Grasshopper Bancorp, Inc. The transaction adds a digital bank platform to Enova's existing fintech and online lending operations. The deal is expected to expand Enova's reach with small business and digitally focused customers. For investors, this move connects Enova International's consumer and small business lending focus with a full digital banking platform at Grasshopper Bancorp, Inc. NYSE:ENVA is already rooted in online...
NasdaqGM:LRMR
NasdaqGM:LRMRBiotechs

Larimar Therapeutics (LRMR) Valuation After FDA Breakthrough Therapy Designation For Nomlabofusp

FDA milestones put Larimar Therapeutics (LRMR) and nomlabofusp in sharper focus Larimar Therapeutics (LRMR) is back on investors’ radar after the FDA granted Breakthrough Therapy Designation to its Friedreich's ataxia candidate nomlabofusp and signaled openness to a surrogate endpoint supporting a potential accelerated approval filing. See our latest analysis for Larimar Therapeutics. The FDA update has arrived alongside a sharp pickup in momentum, with a 1 day share price return of 31.32%...
NasdaqGM:VCYT
NasdaqGM:VCYTBiotechs

Is Veracyte (VCYT) Pricing Reflect Its Genomic Diagnostics Role After Recent Share Price Weakness

If you are wondering whether Veracyte shares are attractively priced right now, you are not alone. This article is built to help you think clearly about what you are paying for. The stock closed at US$35.69, with returns of a 0.9% decline over 7 days, a 15.6% decline over 30 days, a 15.8% decline year to date and a 6.7% decline over 1 year, while the 3 year return sits at 45.0% and the 5 year return at a 42.6% decline. Recent news coverage has focused on Veracyte's position in genomic...
NasdaqGM:IOVA
NasdaqGM:IOVABiotechs

Iovance Biotherapeutics Q4 Loss Narrows To US$0.18 EPS And Tests Bearish Narratives

Iovance Biotherapeutics (IOVA) closed out FY 2025 with fourth quarter revenue of US$86.8 million and a basic EPS loss of US$0.18, alongside a quarterly net loss of US$71.9 million. The company has seen quarterly revenue move from US$73.7 million in Q4 2024 to US$86.8 million in Q4 2025, while basic EPS shifted from a loss of US$0.26 to a loss of US$0.18 over the same period, setting up a results season where investors are weighing growing sales against ongoing losses. With trailing twelve...
NasdaqGS:RXT
NasdaqGS:RXTIT

A Look At Rackspace Technology (RXT) Valuation After The Palantir AI Partnership And Rapid Share Price Rally

Rackspace Technology (RXT) has quickly moved onto many investors’ radars after announcing a partnership with Palantir Technologies that positions the company as a managed services provider for Palantir’s data and AI platforms. See our latest analysis for Rackspace Technology. The Palantir announcement has coincided with a sharp shift in sentiment, with a 7 day share price return of 248.45% and a 30 day share price return of 82.07%. However, the 1 year total shareholder return of 43.41% and 5...
NasdaqGS:CLNE
NasdaqGS:CLNEOil and Gas

How Amazon Warrant-Driven Loss Outlook At Clean Energy Fuels (CLNE) Has Changed Its Investment Story

In February 2026, Clean Energy Fuels reported fourth-quarter 2025 results showing revenue of US$112.32 million and a wider net loss of US$43.00 million, alongside guidance for a 2026 net loss attributable to the company of US$71.00 million to US$66.00 million, excluding unrealized contract impacts and estimated US$47.00 million of Amazon warrant charges. The company also flagged that swings in diesel and natural gas markets, plus variations in Amazon warrant vesting, could materially alter...
NYSE:LNN
NYSE:LNNMachinery

Lindsay Expands Roadway Safety Lineup With New Products And Growth Aims

Lindsay (NYSE:LNN) has introduced two new safety products, the Road Runner Truck-Mounted Attenuator and the AlphaGuard Channelizing Device. The products expand the company’s roadway and work zone safety lineup, targeting construction and traffic management applications. Both launches focus on work zone protection, operational efficiency, and evolving infrastructure management needs. Lindsay, trading at $135.74, is building on its position in roadway and infrastructure safety with these new...
NasdaqGS:IBRX
NasdaqGS:IBRXBiotechs

ImmunityBio (IBRX) Revenue Ramp To US$38 Million Tests Profitability Optimism

ImmunityBio FY 2025 earnings snapshot ImmunityBio (IBRX) has reported its FY 2025 results with Q4 revenue of US$38.3 million and a basic EPS loss of US$0.06, alongside net income loss excluding extra items of US$61.9 million. This puts the focus squarely on how quickly the business can scale to cover its cost base. The company has seen quarterly revenue move from US$7.6 million in Q4 2024 to US$16.5 million in Q1 2025, US$26.4 million in Q2 2025, US$32.1 million in Q3 2025 and US$38.3 million...
NasdaqGS:PICS
NasdaqGS:PICSDiversified Financial

Is It Too Late To Reconsider PicS (PICS) After The Recent 27% Price Jump

If you are wondering whether PicS is attractively priced at its recent levels, this article will walk through what the current numbers are really saying about the stock. The share price recently closed at US$16.81, with a 7 day return of 27.4% and a year to date return of an 11.5% decline. This has caught the attention of investors who are considering the balance between growth potential and risk. Recent news coverage around PicS has focused on its positioning within the diversified...
NasdaqGS:MTCH
NasdaqGS:MTCHInteractive Media and Services

Match Group Board Exits Raise Questions On Future Oversight And Strategy

Pamela Seymon and former CEO Sharmistha Dubey plan to leave Match Group's Board at the 2026 Annual Meeting. The departures will change the board composition at NasdaqGS:MTCH and affect its governance structure. Investors are watching for how these board changes may influence oversight and long term company direction. Match Group, the parent of several online dating platforms, sits at the center of how people form relationships through digital services. As user behavior, regulation, and...
NYSE:SEM
NYSE:SEMHealthcare

Select Medical Take Private Interest Spurs Fresh Look At Valuation Risks

Select Medical Holdings (NYSE:SEM) has received a nonbinding indication of interest to take the company private. A special committee of the Board is currently reviewing the proposal. The approach represents a potential change in ownership structure and corporate control. For shareholders, the timing of this approach comes after a mixed share price record. The stock closed at $14.82, with a 1-year return of a 21.3% decline and a 3-year return of a 6.6% decline. Over 5 years, the share price...
NYSE:SNA
NYSE:SNAMachinery

Snap-on Balances Resilient Sales With Higher Dividend And Ongoing Buybacks

Snap-on (NYSE:SNA) reports resilient sales in a challenging environment, supported by strong product innovation and customer response. The company announces a dividend increase for the sixteenth consecutive year. Snap-on confirms continued share repurchases as part of its capital return program. Snap-on, a long established supplier of tools, equipment, and diagnostics to professional users, is leaning on new products and franchisee feedback as it responds to higher material costs and...
NasdaqGS:NMRK
NasdaqGS:NMRKReal Estate

Newmark Expands Asia Pacific Research Leadership With Singapore Appointment

Newmark Group (NasdaqGS:NMRK) has appointed Shanting Wong as Head of Research in Singapore. The new role is focused on expanding research and analytics coverage across Asia Pacific markets. The appointment reflects the firm’s push to deepen its global research and advisory capabilities. Newmark Group is a global commercial real estate services firm, and research is a core part of how it supports investors, occupiers, and capital markets clients. By adding senior research leadership in...
NYSE:MSA
NYSE:MSACommercial Services

MSA Safety Puts Acquisitions In Focus While Balancing Earnings And Buybacks

MSA Safety (NYSE:MSA) recently highlighted that it is actively pursuing acquisitions to drive inorganic growth. The company’s CEO has put mergers and acquisitions at the forefront, signaling a possible shift in capital allocation priorities. This focus on deal making comes on top of its regular earnings, dividend, and buyback updates. MSA Safety, known for its industrial and personal safety equipment, sits in a segment where scale, product breadth, and customer relationships can matter a...
NasdaqGS:HLIT
NasdaqGS:HLITCommunications

Harmonic Refocuses On Broadband As Partnerships Test Valuation Gap

Harmonic has agreed to sell its Video business to MediaKind, repositioning itself as a pure-play broadband company. The company is integrating its broadband technology with ATX Networks to support cable operators upgrading their networks. A multi-year agreement with izzi in Mexico targets large scale fiber expansion using Harmonic solutions. Harmonic, ticker NasdaqGS:HLIT, is refocusing around broadband at a time when its shares trade at $10.44. The stock shows mixed longer term...
NYSE:ESRT
NYSE:ESRTOffice REITs

Do Empire State Realty Trust's New NYC Leases and Buybacks Reshape ESRT's Core Investment Story?

Empire State Realty Trust reported fourth-quarter 2025 results with higher revenue and net income, renewed and expanded major Manhattan leases with tenants including Burlington, TJ Maxx, JP Morgan Chase, and Nespresso, and completed a US$6,000,000 share repurchase program that retired 891,530 shares. In February 2026, the company reinforced its income profile with first-quarter 2026 common and preferred dividends and highlighted a fully New York City-focused portfolio and award-winning...
NYSE:AS
NYSE:ASLuxury

Amer Sports (AS) Margin Expansion Reinforces Bullish Profitability Narratives Despite Premium P/E

Amer Sports (AS) has just wrapped up FY 2025 with fourth quarter revenue of US$2.1 billion and basic EPS of US$0.24, alongside net income of US$131.5 million. The trailing 12 month figures show revenue of US$6.6 billion and EPS of US$0.77. The company has seen quarterly revenue move from US$1.6 billion in Q4 2024 to US$2.1 billion in Q4 2025, while basic EPS shifted from US$0.03 to US$0.24 over the same period. This sets up a story in which higher earnings and a reported 6.5% net margin over...
NYSE:CWH
NYSE:CWHSpecialty Retail

Assessing Camping World Holdings (CWH) Valuation As Mixed Signals Draw Fresh Investor Attention

Why Camping World Holdings Stock Is Drawing Attention Now Camping World Holdings (CWH) has been on investors’ radar after a stretch of weaker share performance, including a 1-month return of 24.6% and a past 3 months return of 4.2%. At a last close of US$10.85, the company combines annual revenue of about US$6.4b with a reported net income loss of US$54.1 million, giving investors a mix of scale and current profitability questions to weigh. See our latest analysis for Camping World...
NasdaqGS:LFUS
NasdaqGS:LFUSElectronic

Is It Too Late To Consider Littelfuse (LFUS) After A 55% One-Year Rally?

If you are looking at Littelfuse and wondering whether the recent price puts the stock on sale or at a premium, the key question is what you are really paying for at today's level. The share price recently closed at US$368.60, with returns of 5.4% over 7 days, 27.0% over 30 days, 40.4% year to date and 54.7% over 1 year, which naturally raises questions about how much of the story is already in the price. Alongside these moves, recent news flow around Littelfuse has focused on its position...
NasdaqGM:HRMY
NasdaqGM:HRMYPharmaceuticals

Harmony Biosciences (HRMY) Margin Compression In FY 2025 Tests Bullish Profitability Narrative

Latest FY 2025 Results Set the Stage for Margin Questions Harmony Biosciences Holdings (HRMY) closed out FY 2025 with Q4 revenue of US$243.8 million and basic EPS of US$0.39, alongside trailing 12 month revenue of US$868.5 million and EPS of US$2.76 that anchors the full year picture. The company has seen quarterly revenue move from US$201.3 million in Q4 2024 to US$243.8 million in Q4 2025. Over the same period, basic EPS shifted from US$0.87 to US$0.39, giving investors a clear view of how...
NYSE:PRA
NYSE:PRAInsurance

ProAssurance (PRA) Combined Ratios Above 100% Reinforce Cautious Underwriting Narratives

ProAssurance (PRA) has wrapped up FY 2025 with fourth quarter revenue of US$259.6 million and basic EPS of US$0.65, alongside net income of US$33.4 million, giving investors a clean snapshot of its latest underwriting and investment performance. Over the last six reported quarters, the company has seen quarterly revenue range between US$259.6 million and US$289.1 million, while basic EPS has moved from a loss of US$0.11 in early 2025 to positive readings such as US$0.32 in late 2024 and...
NYSE:NVRI
NYSE:NVRICommercial Services

Enviri (NVRI) EPS Loss Deepens In Q4 FY 2025 Reinforcing Profitability Concerns

Enviri (NVRI) has wrapped up FY 2025 with fourth quarter revenue of US$556.4 million and a basic EPS loss of US$1.07, alongside trailing twelve month revenue of US$2.2 billion and a basic EPS loss of US$2.03. Over recent quarters, the company has seen revenue move in a tight band between US$548.3 million and US$574.8 million, while quarterly basic EPS losses have ranged from US$0.15 to US$1.07. This sets a clear context of steady top line and persistent negative earnings. With shares at...
NYSE:JBTM
NYSE:JBTMMachinery

JBT Marel (JBTM) Q4 Return To Positive EPS Tests Turnaround Narratives

JBT Marel (JBTM) closed out FY 2025 with Q4 revenue of US$1.0b and basic EPS of US$1.02, capping a year in which quarterly revenue moved from US$854.1m in Q1 to US$934.8m in Q2, US$1.0b in Q3 and US$1.0b in Q4 while EPS swung from a Q1 loss of US$3.35 per share to US$0.07 in Q2, US$1.28 in Q3 and US$1.02 in Q4. Against that backdrop, the story for investors now turns to how much of this shift in earnings power is sustainable and what it means for margins as the market weighs the new...
NYSE:TNC
NYSE:TNCMachinery

Tennant (TNC) Margin Compression To 3.6% Tests Bullish Growth Narratives

Tennant (TNC) just wrapped up FY 2025 with fourth quarter revenue of US$291.6 million and a basic EPS loss of US$0.25. This rounds out a trailing 12 month EPS of US$2.38 on US$1.2 billion of revenue and a net profit margin of 3.6%, which includes a one off loss of US$32.7 million. Over the last six reported quarters, revenue has ranged from US$290 million to US$328.9 million while quarterly EPS has swung between a loss of US$0.25 and a profit of US$1.11. This has left investors focused on how...